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 Adequate medication management is a focus of effective care that is often overlooked in 
caring for adults with comorbid psychiatric and physical conditions, especially in patients who 
are treated by multiple care providers and have a variety of health issues at the same time. The 
purpose of this project was to develop evidence-based policies and practice guidelines to reduce 
polypharmacy in elderly patients in a rural outpatient psychiatric clinic. Bandura’s self-efficacy 
theory was used to inform the project for its value in assessing motivation, capacity for self-
regulation, and perceptions of individual ability. An interdisciplinary team of stakeholders 
explored best practices for electronic health records (EHR) in a rural mental health facility, 
created policy and practice guidelines, and developed implementation and evaluation plans to 
guide the initiative as it moves forward. The team included physicians, psychiatrists, 
psychologists, nurse practitioners, nursing support staff, social workers, and substance abuse 
counselors. The team explored approaches for implementing EHR–based medication 
management based on research in the current literature and goals/objectives of each department. 
Team members identified major issues and proposed guideline changes based on evidence in 
their own fields. The team then collaborated to develop policies and practice guidelines in a 
series of meetings designed to build consensus for supporting a unified set of products to be 
accepted by all departments. The resulting policies and practice guidelines are accompanied by 
plans for implementation and evaluation that provide the institution with a comprehensive 
solution to polypharmacy in elderly patients. This project may improve overall quality of care by 
reducing medication and preventing health complications related to polypharmacy. 
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Section 1: Nature of the Project 
Introduction 
Polypharmacy in populations of adults age 65 or older is a significant issue, especially in 
populations receiving care in mental health facilities. In this evidence-based project, I assessed 
the problem of polypharmacy from a variety of perspectives, provided a definition for 
polypharmacy for this specific population, and proposed a method that can be implemented to 
create greater accountability in addressing the needs of an aging population through the use of 
electronic health records (EHRs). When implemented, this project will have the potential of 
changing the way in which healthcare professionals address the needs of their patients in rural 
health clinics, including assessing their medication needs and seeking information that can 
prevent polypharmacy in this vulnerable population through the use of improved technologies.  
Background 
 Medical advancements in the 20th century and improvements in the quality of life across 
populations have led to improvements in longevity in the United States. This has led to the aging 
of the American society, which brings about increasing healthcare needs for older adults (CDC, 
2013). The percentage of the population over the age of 65 will increase to more than 20% by 
2030, and this population currently consumes more than 66% of the country’s outlay for 
healthcare (CDC, 2013). Estimates suggest that unless there is another major shift by 2050, 
Americans over the age of 65 will exceed 89 million (CDC, 2013).  
These figures demonstrate the breadth of the challenge that emerges when attempting to 
meet the healthcare needs of the population over the age of 65. Over the course of their lifespans, 
people develop many different conditions impacting health, and chronic disease is more common 
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in this population than in any other. Conditions prevalent in this population include heart disease, 
cancer, diabetes, and mental illness, all of which are frequently treated pharmacologically (CDC, 
2013). Therefore, the threat of polypharmacy, or the overprescribing of multiple medications, is 
especially problematic for this vulnerable population.    
 Inappropriate drug use in elderly populations occurs in about 14% of community-
dwelling patients and rises to 40% among nursing home residents (Trivalle et al., 2010). 
Subsequently, the problem of polypharmacy is becoming increasingly common in older adults 
and poses considerable challenges for practitioners, including nurse practitioners working in 
psychiatric outpatient clinics in rural settings. Developing methods and strategies to improve 
patient outcomes and to reduce adverse events is becoming a necessary component of care for 
elderly patients.  
Problem Statement 
The problem focused on in this project is the way in which nurses and other professionals 
address the issue of polypharmacy in elderly patients in rural outpatient psychiatric clinics. 
Polypharmacy is the use of multiple medications to treat a single illness or a syndrome in one 
individual patient. It is a common practice among the elderly, both for physical health issues and 
mental health issues. One of the confounding issues in the rural psychiatric clinic where I 
practice is that most elderly psychiatric patients have more than one chronic illness; they often 
have several. Many researchers have shown that these elderly patients are receiving several 
prescriptions from different physicians that may increase their risk for adverse drug reactions. 
Adequate management of patient medication regimens can be a difficult component of 
care, primarily because many practitioners rely on reports from patients about their medications, 
3 
 
both prescribed and over-the-counter, in order to determine the need for additional medications 
or if adverse interactions might occur. This results in the problem of polypharmacy, which Viktil 
et al., (2007) described as “the concurrent use of multiple drugs … the use of more drugs than 
are clinically indicated or too many inappropriate drugs” (p. 187). Hoffman et al.,  (2011) 
maintained that this can sometimes reflect an imprecise view of the overall problem in relation to 
psychiatric patients, so they more clearly defined polypharmacy for this population as the use of 
two or more medications in the same patient to treat the same condition, or the use of two or 
more of the same chemical class of medications used to treat the same psychiatric ailment.  
 For geriatric psychiatric patients who often have multiple comorbid psychiatric and 
physical conditions, polypharmacy can result from the use of multiple psychiatric drugs, multiple 
prescribers, and/or the use of drugs that result in adverse drug reactions because of the lack of 
continuity in communications regarding overlapping medication regimens (Hoffman et al., 
2011). Slabaugh et al., (2010) also maintained that polypharmacy can complicate the treatment 
process for elderly patients who have multifactorial health states and require medications for 
psychiatric conditions. Another problem for elderly populations is that medication regimens may 
become less effective over time, resulting in the perceived need for additional medications, 
especially in the treatment of psychiatric conditions (Bilyeu et al., 2011).  
Purpose Statement 
The purpose of this DNP project was to create a quality improvement program with the 
aim of reducing polypharmacy in elderly patients in a rural outpatient psychiatric clinic. This 
quality improvement program focused on three specific areas designed to reduce polypharmacy:  
1. Identifying all medications, prescribed and over-the-counter, used by each patient;  
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2. Increasing patient understanding of the purpose and side effects of each medication; and  
3. Improving communications between practitioners to reduce the opportunities for 
polypharmacy.  
The focus of this project was the incorporation of new policies and systems in a 
multidisciplinary team approach to improving patient care. 
Goals and Outcomes 
The goal of this project was to create a quality improvement program with the aim of 
reducing polypharmacy in elderly patients in a rural outpatient psychiatric clinic. The goal of 
developing the project to reduce polypharmacy required the ability to assess current perspectives 
on changing the present system and the level of commitment that individuals have to improving 
patient outcomes. 
  For the purpose of assessing perspectives on the planned change, the definition of 
polypharmacy reflected the concurrent use of multiple drugs for the treatment of the same 
clinically indicated illness and the presence of inappropriate drug use, or the use of multiple drugs 
in a manner that is ineffective, excessive, or can result in adverse events (Viktil et al., 2007). 
Creating a multidisciplinary approach to reducing polypharmacy required an assessment of current 
systems, the creation of recommendations from the multidisciplinary team for change, and an 
assessment of the views of practitioners about their commitment to reducing the problem of 
polypharmacy.  
The most significant measurable outcomes for this project at the time it was proposed 
were to demonstrate reduction in polypharmacy from current levels to no incidences after 
implementation of the multidisciplinary team-initiated EHR project. Because no level of 
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polypharmacy would be acceptable and because of the severity of adverse reactions for the elderly 
population studied, the use of EHRs as a change in protocol was believed to ensure reduction to 
zero events after implementation. The EHR system identifies when three or more medications are 
being prescribed for a single patient to treat the same condition, so different providers have the 
option to go back in and assess their prescribing decisions to prevent polypharmacy. Once the 
EHR alerts the prescribing professional of the presence of polypharmacy resulting from their 
prescribing choice, they can then initiate discourse with the other professionals and refrain from 
their current prescribing plan as a way to prevent polypharmacy. Subsequently, the use of EHRs in 
combination with the multidisciplinary method was viewed as an approach to use; the technology 
and the protocols for addressing polypharmacy could reduce the level of polypharmacy in the rural 
facility to zero.  
Frameworks for the Project 
The quality improvement program was defined by a multidisciplinary model that 
enhanced communications and improved identification of risk factors for polypharmacy. In 
correlation with this approach, though, a nursing theory was applied to the focus of educational 
support services and improved patient participation. Creating a system that supported more 
effective communication had to start with an effective understanding of treatment modalities and a 
self-awareness for the patients themselves. This included a focus on self-efficacy theory. Self-
efficacy theory can be used to assess a person’s motivation, capacity for self-regulation, and 
perceptions regarding individual ability to meet particular end goals, including effective 
medication management (Bandura, 1997). Self-efficacy theory was applied to health promotion 
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activities for patients that are based on a patient’s choices and behaviors and the adaptations 
necessary for change.   
Nature of the Project 
This evidence-based project focused on the implementation of an EHR-based approach 
that ensured the documentation and sharing of information about patient care across 
multidisciplinary teams and ensured improved information sharing for the treatment of elderly 
populations in a rural psychiatric outpatient facility. The rationale for this approach was the 
belief that this type of method could be effective in reducing adverse events that occur as a result 
of polypharmacy through closer tracking of patient drug use (Viktil et al., 2007). The creation of 
this program and the strategies for implementation focused on the specific use for elderly 
patients who are at greater risk of polypharmacy and the perceived benefits of and resistance to 
this kind of approach in reducing the problem. 
Significance of the Project 
Elderly populations seeking treatment in rural psychiatric outpatient clinics may have a 
long history of psychiatric disorders and demonstrate problems that range from effective 
adherence to medication regimens to the need for periodic and/or systematic changes in 
medication that can impact the level of control over the psychiatric disorder (Greenawalt, 2009; 
Hoffman et al., 2011; Hogan & Kwan, 2006). For example, an elderly patient may have 
experienced years of well-controlled bipolar disorder and may find that he or she is suddenly 
experiencing symptoms. This patient may be treated by one or more practitioners, who may 
prescribe a range of medications to treat the symptoms. Changes in physiological processing of 
medication and changing levels of response to medication may result in a variety of different 
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views on the best treatment modalities for the patient. In addition, the presence of comorbid 
health conditions and medications can result in polypharmacy that has a negative impact on the 
patient’s psychiatric and physical condition.  
Most practitioners reflect on the patient’s history, including prescribing history, as a part 
of their evaluation of the need for new medications (Hutchinson, 2008). At the same time, a 
focus on patient self-reports of medication and the present use levels for medication does not 
always reflect a full and complete assessment of the medication regimen. Subsequently, 
practitioners need to determine more effective strategies for gaining insight into patient 
medication use, medication regimens prescribed, and the potential for adverse events each time a 
patient presents in the rural psychiatric outpatient clinic.  
The significance of the project related directly to the increase in the number of elderly 
patients seeking services, the increasing need for effective medication management, and the 
noted number of adverse events that occur as a result of medication mismanagement. There were 
approximately 40 million people living in the United States over the age of 65 in 2010, which 
comprises about 13% of the population. That number will jump to over 72 million in 2030, 
increasing to about 20% of the population (Federal Interagency Forum on Aging-Related 
Statistics, 2012).  
There are distinct physiological and psychological changes that occur with age. Elderly 
adults experience changes that impact how medications are processed, and this can change 
expected outcomes of medications. Specifically, bioavailability can be impacted by age, and this 
is reflective of changes that correspond with aging, including weight gain, changes in excess fat 
deposition, and changes in GI processing, increased levels of stress, and decreased levels of 
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physical activity (Porter & Kaplan, 2012). As people age, their metabolism of medications can 
slow, and this corresponds both with a general slowing of their metabolism and the impacts of 
physical condition, all of which require adjustments to drug interventions or therapies that are 
being used for elderly patients. 
Patients aged 65 and older often experience suboptimal pharmacotherapy, primarily 
because of changes in drug metabolism, target organ sensitivity, problematic drug interactions, 
and even drug toxicity (Trivalle et al., 2010). Commonly, these changes result in longer periods 
of drug activity, which can have a greater or lesser drug effect, and an increased level of 
potential toxicity resulting from metabolic changes (Trivalle et al., 2010). Cefalu (2006) 
maintained that while this predisposition to adverse reactions occurs in populations over the age 
of 65, the most problematic outcomes of these reactions occur in patients over the age of 85, who 
can take an average of five to eight drugs each day.  Cefalu stated that a number of reports have 
shown that the risk of adverse drug events in elderly patients rises with comorbidity; increasing 
numbers of medications; inappropriate medications; the use of antipsychotics, anticoagulants, 
diuretics, and antiepileptics; and the use of multiple prescribers and pharmacies by patients and 
caregivers.   
The use of a patient profile and pharmacology questionnaire should occur at each visit, 
including an identification of any alternative treatments or supplements that could interfere with 
the function of other drugs. Sharing this information through the use of electronic health records 





Implications for Social Change 
Disease rates have decreased over the last quarter century, at the same time that life 
expectancy rates of the elderly have increased for both men and women (FIFARS, 2012). 
Longevity has led to the increasing need for medical services, including services for both 
psychiatric and physiological health concerns. Many people over the age of  have prescriptive 
and nonprescriptive medications used to treat pain, inflammation, and problematic symptoms 
related to their conditions. Men and women over 65 are more likely than any other single 
population to take multiple medications at one time. While some of these medications may be 
prescribed, it is not uncommon for patients to use a combination of prescribed medication and 
over-the-counter drugs and supplements that can result in problematic interactions.  
Inappropriate drug use in elderly populations occurs in about 14% of community-
dwelling patients rising to 40% in nursing home residents (Trivalle et al., 2010). Subsequently, 
the problem of polypharmacy is becoming increasingly common in older adults and poses 
considerable challenges for practitioners, including nurse practitioners working in psychiatric 
outpatient clinics in rural settings. Developing methods and strategies to improve patient 
outcomes and reduce adverse events is becoming a necessary component of care for elderly 
patients.  
Definitions of Terms 
Adverse drug events (or Adverse medication events): Adverse drug events, or adverse 
medication events, occur when a patient’s medication is not managed effectively and the patient 
experiences physiological or psychological responses that are undesirable, including decline in 
health or mental status resulting from the level, combination or type of medications used.  
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Electronic health records: A technology-based documentation and charting system that 
provides practitioners and clinicians with access to patient information at a wide range including 
remote locations to ensure the accuracy of patient health information that informs medical 
treatment.  
Inappropriate drug use: Inappropriate drug use is drug use that is either ineffective, 
excessive, or results in adverse medication events (Trivalle et al., 2010).  
Polypharmacy: Polypharmacy can be described as “the concurrent use of multiple 
drugs,[or]…the use of more drugs than are clinically indicated or too many inappropriate drugs” 
(Viktil et al., 2007, p. 187).  
Quality improvement program: The quality improvement program used for this DNP 
project will focus on closer scrutiny and documentation of patient prescribing regimens and 
medication intake, scrutiny of each patient’s regimen, and more effective communication within 
a multidisciplinary team. This quality improvement program will be supported by evidence-
based practices identified in the current literature.  
Rural outpatient psychiatric clinic: The rural outpatient psychiatric clinic used for the 
purpose of this study is a facility that provides services for patients with psychiatric disorders 
that can be managed through medication and support services while residing at home. In this 
case, the psychiatric outpatient clinic is one located in a rural area and generally provides 
services for a patient population living within 40 miles of the clinic.  
Assumptions and Limitations 
The assumption at the onset of this study was that the problem of polypharmacy existed 
in the general population and would be found to some degree in participants in a rural psychiatric 
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outpatient facility. This study was also based on the assumption that other mitigating factors, 
including decreased educational level of rural patients and decreased communication between 
practitioners using electronic medical records, played a role in the level of polypharmacy in this 
facility. The study was limited by the focus on a single rural facility and the willingness of 
practitioners on the multidisciplinary team to support transitions from the protocols currently in 
place.  
Summary 
In this project, I focused on the level of service being provided to patients in a rural 
outpatient psychiatric clinic, especially in relation to the use of medication regimens. One of the 
struggles that practitioners in this kind of setting had was that they often were not fully aware of 
the level of medication that a patient was taking and may have prescribed more than one 
medication for the same condition or may have experienced difficulties in assessing the 
medications a patient is taking. A strategy that was beneficial to support patients in this setting in 
reducing adverse events, especially in elderly populations, was to support a level of patient 
education and patient/practitioner communication that was maintained by a multidisciplinary 
team. In this project, I assessed the level of polypharmacy for elderly patients in this clinical 
setting and considered the implications of creating improved services, focusing on the use of 




Section 2: Review of Literature and Theoretical and Conceptual Framework 
Introduction 
This project was designed to assess the impact of a quality improvement program 
designed to address the problem of polypharmacy in elderly patients in a rural outpatient 
psychiatric clinic. This problem was identified in a variety of studies about polypharmacy, 
adverse events, issues in elderly medical care, and in the presence of comorbid conditions in 
elderly populations. Current studies on the changing nature of the elderly population, increasing 
issues with medication management, and the need for better methods of communication were all 
a part of the review of literature provided (Cefalu, 2006; Greenawalt, 2009; Hoffman et al., 
2011; Hogan & Kwan, 2006; Hutchinson, 2008; Porter & Kaplan, 2012; Trivalle et al., 2010; 
Viktil et al., 2007). 
The review of literature includes an overview of the literature search strategy and an 
identification of major models and theories used to support the change initiative. The literature 
was used to identify the scope of the problem in the specific context of care in the rural 
outpatient mental health facility. The relevant literature selected demonstrated the scope of the 
problem and the strategies that were used in the past, including the use of medical records, to 
support positive outcomes in reducing polypharmacy. 
Literature Search Strategy 
An initial Google Scholar search was conducted to determine if any recent online 
resources could be located in full-text and to determine if other search terms should be used. 
Some of the search terms considered for this project included polypharmacy, elderly, adverse 
events, mental health, electronic medical records, and electronic health records.  Other terms, 
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including hospital and nursing, were included to distinguish medical studies from studies in 
other fields (e.g., social services) in which assessments of adverse events might occur.  The 
search that produced the most potential sources in Google Scholar was one that used the terms 
polypharmacy and elderly and also limited sources to nursing journals. This search produced 711 
results that included studies on polypharmacy in the elderly, adverse events in the elderly, and 
views of strategies used to prevent adverse events. Of the first two pages of results, though, only 
four sources had any reference to a specific focus on comparisons of different strategies that 
were used with patients.  
 A search of the CINHAL, Healthsource, and Medline databases produced a much 
smaller body of overall literature. One of the key aspects of the search was to limit to full-text 
sources in order to ensure that the resources could be viewed and used. After completing a search 
limited by data (2006-2014), full-text status, and peer reviewed sources, a search of the terms 
polypharmacy and elderly and also limited sources to nursing journals resulted in 41 full-text 
studies, only 17 of which pertained to the topic being investigated. The sources selected included 
those that addressed some of these separate parameters as a foundation for a study on the link 
between adverse events and polypharmacy, especially in patients with mental illness.  
The body of evidence that was produced from a search of terms related to the impact of 
polypharmacy in elderly patients in the rural mental health setting presented a range of 
information that included surveyed responses, a focus group, and a retrospective review of 
patient data. One of the key issues in exploring this topic was that many of the studies that were 
produced to support hospital redesign measures were carried out in the early 2000s, and much of 
the current literature focused on the end products of specific design approaches, including 
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methods of improving patient safety and the use of medical health records. The lack of current 
literature that indicated the benefits of this kind of change in rural mental health facilities 
produced the gap in literature that suggested the need for the benefits of the proposed approach.  
Scope of the Problem 
The existing literature related the scope of the problem of polypharmacy in elderly 
populations to the increasing number of elderly in this country. In 2009, approximately 12.9% of 
the U.S. population was over the age of 65, amounting to approximately 39.6 million people 
(Administration on Aging, 2014). This number is expected to almost double by 2030, reaching 
72.1 million people (American Agency on Aging, 2014).  
In addition to comprising a large segment of the population, people over the age of 65 
comprise a significant portion of the population using pharmaceuticals. Elderly populations use 
more than 50% of all prescribed medications and 40% of all over-the-counter medications in this 
country (Pretorius et al., 2013). More than 90% of all elderly patients not institutionalized are 
taking at least one form of prescription medication on a regular basis (Pretorius et al., 2013). For 
those actively participating in regular healthcare-related maintenance, elderly people over the age 
of 65 are likely to have six to eight medications they are taking at the same time to address a 
range of comorbid health conditions (Pretorius et al., 2013). As the number of medications being 
prescribed or used increases in this population, the risk of adverse events also increases. Fulton 
and Allen (2005) identified the risks of the use of two medications at 15% for elderly 
populations, while that risk level increases to 58% with five medications and to 82% with seven 
medications. These researchers further asserted that as the number of medications increases, the 
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risk for adverse events also increases, and this defined the impetus for relating literature about 
this problem.  
Risks for Psychiatric Populations: Background and Context 
A variety of literature has indicated that polypharmacy is particularly problematic in 
geriatric patients and in psychiatric populations (Langan & Shajahan, 2010; Tiihonen et al., 
2012; Zink, Englisch, & Meyer-Lindberg, 2010). While the current literature reflected the nature 
of this problem in regards to psychiatric patients in clinical settings, the assumption that these 
individuals were uninvolved in their medication management was a general misnomer 
recognized by researchers, including Mizokami et al., (2012) and Munger (2010). Literature has 
indicated that communications and effective medication management is a cooperative element 
requiring compliance, support, and regular assessments in order to reduce the chances of 
problematic medication mismanagement (Tiihonen et al., 2011).  Existing literature has 
maintained the importance of the use of technology and the use of patient support mechanisms to 
reduce the chances of polypharmacy that results in adverse events (Langan & Shajahan, 2010). 
Suokas et al., (2013) conducted a large nationwide study to determine the prevalence and 
potential predictors of long-term polypharmacy specific to patients receiving treatment for 
schizophrenia. This project specifically focused on the impacts of antipsychotic polypharmacy in 
patients and reflected on those who had experienced at least one hospitalization during the study 
period for schizophrenia (Suokas et al., 2013). The researchers conducted a cohort study defined 
by the presence of hospitalization for schizophrenia between 2000 and 2007 in order to 
determine if antipsychotic polypharmacy had occurred. Because of the precarious nature of 
treatment modalities for patients with schizophrenia, these researchers identified the problem of 
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polypharmacy simply as patients being prescribed two or more overlapping prescriptions for 
different antipsychotics in a 60-day period (Suokas et al., 2013). They found that patients with 
schizophrenia and antipsychotic polypharmacy were at an unacceptable level, with more than 
46% of patients experiencing this problem. In addition, the researchers posited that there were 
implications that this kind of prescribing mismanagement in the case of schizophrenic patients 
will possibly require hospitalization.  
Literature specific to the issue of polypharmacy in elderly patients with psychiatric 
disorders referred to the connections amongst changing psychiatric medications, the changes in 
patient needs, and the comorbid conditions that exist for elderly patients, all of which can 
increase the risk of polypharmacy. This specific project provided a foundation for understanding 
the overall problem and could subsequently be applied to the scrutiny of the process at a rural 
outpatient psychiatric clinic.  
Patient Health Worldwide 
Research about polypharmacy and its potential impacts has been conducted in the 
international community for decades. Sato and Akazawa (2013), for example, maintained that it 
is common in Japan for elderly populations to have multiple comorbidities and to be medicated 
by multiple practitioners, increasing the chances that individuals will experience adverse drug 
reactions. These researchers further maintained that the risk of adverse drug reactions increases 
when patients are taking five or more medications and when they are being treated for both 
psychiatric and physiological health issues. In Japan, this is especially true of a growing 
population of elderly patients who are hypertensive and being treated for psychiatric conditions, 
amongst others (Sato & Akazawa, 2013).  One of the notable elements in this Japanese study is 
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that researchers found there were times when multiple medications were being used to treat the 
same condition, which both was unnecessary and increased the risk of adverse events.  
Other studies in international populations also underscored the problem of polypharmacy 
in elderly populations and the increased risk of problematic health impacts. For example, Jyrkk 
et al., (2009) assessed populations of elderly patients in Finland and found that adverse 
physiological implications could also be assessed as a result of polypharmacy. The researchers 
found that it was not uncommon for elderly patients receiving multiple medications, some for the 
same conditions, to experience greater levels of physical instability. Subsequently, elderly 
patients in their Finnish cohort study demonstrated a higher degree of physiological instability 
leading to falls and individual injury resulting from polypharmacy (described as the use of six to 
nine drugs) or excessive polypharmacy (the use of 10 or more drugs; Jyrkk et al., 2009). The 
researchers found that excessive polypharmacy was a significant underlying cause of increased 
mortality rates amongst elderly populations and indicated the importance of addressing the issue 
of multiple prescribing physicians’ communications and the need for improved medication 
management in order to decrease the use of multiple medications for the same conditions (Jyrkk 
et al., 2009).  
In an Egyptian study of elderly populations, researchers found that polypharmacy and the 
inappropriate use of certain types of medication was more common in elderly patients than in 
any other population (Hamza et al., 2012). The researchers studied populations of people over 
the age of 60 and found that polypharmacy occurred in 56% of the subjects studied, and this 
included the use of prescribed medications from multiple practitioners. Inappropriate use of 
medications was especially high in this population, with about 41% receiving inappropriate or 
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poorly managed medications, including contraindicated medication combinations (Hamza et al., 
2012). Because the use of antidepressants and antipsychotic medications in elderly populations is 
on the rise, the significant association between the use of multiple practitioners and 
polypharmacy was an element identified in the study as increasing the risk of adverse events 
(Hamza et al., 2012).  
In a study of subjects in Sweden, Haider et al., (2009) maintained that a range of factors 
can impact the effectiveness of medication management and can serve to foster problematic 
adverse drug events in patients with medical and psychiatric comorbidities. Researchers in this 
study evaluated the impacts of low levels of educational attainment on the ability of elderly 
patients to assess and self-manage their medication regimen. These researchers maintained that a 
lower educational level was associated with a higher degree of polypharmacy and the potential 
for adverse events occurring from inappropriate drug use (Haider et al., 2009). Lower levels of 
educational attainment increased the risk of individuals taking three or more psychotropic drugs, 
and these individuals had a high level of adverse events resulting from polypharmacy, especially 
when comorbidity between psychiatric and physiological issues emerged (Haider et al., 2009).  
In a study of Nigerian patients, prescribing patterns for patients over the age of 65 years 
suggested a very high level of inappropriate medication use, primarily because of the presence of 
multiple practitioners and lack of effective medication self-management by patients (Fadare et 
al., 2013).  After evaluating medical records for 220 patients, the researchers found that the 
patients were prescribed an average of almost four medications per person, including 
medications for hypertension as well as medications for psychological conditions. Polypharmacy 
that could result in adverse events (specifically, potentially inappropriate medication prescribing) 
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occurred in almost 26% of the cases. Similarly, Chirn-Bin et al., (2011) maintained that elderly 
patients in a Taiwan study experienced inappropriate prescribing with significant frequency, 
resulting in adverse events occurring as often as 24% of the time. One of the problems that 
emerged, as noted by Chirn-Bin et al., is that medication regimens are often not assessed until 
patients experience an adverse event. For elderly patients who may already be experiencing 
physiological fragility, waiting until an adverse event occurs to address polypharmacy is a risky 
proposition.  
Salih et al., (2013) explored polypharmacy in outpatient clinics in Saudi Arabia and 
found that of 766 patients, 89% were taking five or more medications prescribed by physicians 
each day. The most frequently treated conditions included hypertension, diabetes mellitus, and 
dyslipidemia, but a range of other conditions also existed, including depression, cardiovascular 
disease, and pain management medications. The presence of polypharmacy and the risk of 
adverse events are often discussed in contrast to appropriate medication management and the 
focus for elderly patients on medication compliance (Salih et al., 2013).  As a result, the World 
Health Organization has sought to determine ways of reducing polypharmacy in geriatric 
patients, recognizing that many elderly experience polypharmacy as they are treated for a range 
of conditions, including psychiatric diseases, by different practitioners (as cited in Shah, Gajjar, 
& Desai, 2012).  The World Health Organization has identified an imperative to improve the 
quality of care for geriatric patients and to promote the rational use of medications through 
increased communication and patient medication management systems.  
The general literature provided an understanding of the issue of polypharmacy as a whole 
and the potential risks involved. The literature showed studies from all over the world that 
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indicated that even in areas where technology is commonly applied, the use of multiple 
prescribing practitioners and the lack of adequate patient information resulted in poor outcomes 
for patients. This information also furthered an understanding of the specific issues for elderly 
patients, many of whom experienced comorbid conditions that resulted in a wide range of 
medications and potential adverse medication reactions.  
The Application of Quality Improvement Strategies: Concepts, Models, and Theories 
The quality improvement program was defined by a multidisciplinary model that 
enhanced communications and improved identification of risk factors for polypharmacy. In 
correlation with this approach, though, a nursing theory was also applied to the focus of 
educational support services and improved patient participation. Creating a system that supported 
more effective communication had to start with effective understanding of treatment modalities 
and self-awareness in the patients themselves. This included a focus on self-efficacy theory. Self-
efficacy theory could be used to assess a person’s motivation, capacity for self-regulation, and 
perceptions regarding individual ability to meet particular end goals, including effective 
medication management (Bandura, 1997). Self-efficacy theory could be applied to health 
promotion activities for patients who are based on a patient’s choices and behaviors and the 
adaptations necessary for change.   
Self-efficacy theory is based on the “beliefs in one’s capabilities to organize and execute 
the courses of action required producing given attainments” (Bandura, 1997, p. 3). In using self-
efficacy theory as a foundation for promoting health, it is important to recognize that self-
efficacy is behavior-specific and reflects beliefs and perceptions regarding one’s own skills and 
abilities and their application. Self-efficacy generally describes the perceptions and feelings a 
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person has towards goal achievement and his or her own participation in transformative 
behaviors. Self-efficacy relates to both internal and external cues and individuals and social 
messages that can impact a person’s motivation, self-confidence, and perceptions regarding 
capacity to reach health promotion goals, including reduction of polypharmacy and the patient’s 
effective self-management of medication regimens.  
The connection between self-efficacy theory and any program developed to determine 
methods to reduce polypharmacy should be education-based and should focus on methods of 
supporting improved interactions between practitioners in the clinical setting and patients 
requiring support. The connection between methods for improving outcomes and specific 
approaches utilized by patients to take part in their care suggested a beneficial line to explore as 
a part of programming to reduce polypharmacy.  
Measuring Polypharmacy: Framework 
There are two strategies for measuring polypharmacy and specifically providing data for 
the evaluation of measures to reduce polypharmacy through the use of electronic health records 
(EHRs): the use of a patient questionnaire before and after implementation of the change 
initiative or the comparison of health record data and comparisons before and after 
implementation of EHR use. Studies that reflect the use of both of these measures are identifying 
the issue of polypharmacy in this particular population and creating a body of comparative data. 
Rambhade et al., (2012), for example, created a questionnaire that was specifically designed to 
assess polypharmacy by reviewing demographic information, prescribing physicians, date of 
prescriptions, purpose of the use of the prescription in medical treatment, a complete list of 
current medical conditions, and any signs and symptoms related to the use of medications.  The 
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information in the study by Rambhade et al., (2012) was collected using the questionnaire 
categories as the survey instrument and semi-structured patient interviews.  Before the onset of 
the interview, patients agreeing to participation were asked to bring a list of all their medications 
and prescription dates to the interview, as well as any over-the-counter medications they were 
taking not prescribed by a physician. This type of interview provided a large body of current data 
and the same type of interviews can be conducted following the implementation of an electronic 
health record system in order to evaluate the implications for reducing polypharmacy.  
Another option for measuring reductions in polypharmacy would be to assess the level of 
medication use and the specific patient diagnoses in a population in a health facility utilizing 
traditional recording methods, and comparisons with the electronic medical record data that can 
be collected after implementation. Freund, Meiman and Kraus (2013) demonstrated the use of 
medical records to characterize the level of medication use based on demographic characteristics, 
including age, and the evaluation of polypharmacy in relation to specific patient conditions 
identified through the use of this electronic data.  This approach to evaluating data allowed for 
the application of a retrospective inquiry into patient medication use, categories of medication 
prescribed, and prescribing conditions, all of which was derived in correlation with patient 
demographics and comorbidities. When assessing this kind of data, Freund, Meiman and Kraus 
(2013) found that patients in older demographic groups had a much higher level of 
polypharmacy and comorbidity than younger groups, placing them at higher risk of adverse 
events.   
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Section 3: Methodology 
Introduction 
In this quality improvement project, I used a multidisciplinary team to determine 
protocols for the use of EHRs with the aim of reducing polypharmacy for geriatric patients 
seeking treatment in a rural outpatient psychiatric clinic. The purpose of this DNP project was to 
create a quality improvement program with the aim of reducing polypharmacy in elderly patients 
in a rural outpatient psychiatric clinic. 
Overall Approach/Rationale 
The overall approach to developing a multidisciplinary team approach was to address the 
problem of polypharmacy based on the need to determine the best route for change and to 
determine a collaborative set of policies that ensured adequate communication across 
departments. The following activities were central to the progression of the quality improvement 
initiative from an initial idea to an applicable set of steps that was implemented: 
1. I acted as the leader of a multidisciplinary team created to develop a quality improvement 
program based on EHR technology to reduce polypharmacy. The team included a range of 
different institutional stakeholders, with individuals responsible for prescribing medication for 
this population. As a result, I was responsible for selecting and integrating members of a 
multidisciplinary team in the development of policies and protocols to reduce polypharmacy. 
2. I led the multidisciplinary team in exploring studies on the use of EHRs in reducing 
medication polypharmacy and adverse events caused by medication errors (Croll, 2010; Jha et 
al., 2010).  
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3. I led the project term to develop policy and practice guidelines. 
4. I validated the content of policies and practice guidelines by sharing the information with 
scholars in the field. This provided a foundation for assessing the mechanisms for change in 
alignment with their views of evidence-based approaches.  
5. I led the project team to develop an implementation plan and an evaluation plan (See 
Appendix C and D). 
6. This approach provided a cost-effective system for creating a change initiative because it 
focused on my work in leading a team and creating the plan.  
Assembling the Team 
I approached departmental leaders at a rural psychiatric facility and outlined the project 
parameters.  The departmental leaders were then asked to provide recommendations within their 
departments for participants in the project team.  After collecting a document of potential 
candidates for participation in the team, members of each of the multidisciplinary stakeholder 
groups were approached and asked to participate.  This process continued until at least one 
member of each stakeholder group was identified for participation in the team.  
The multidisciplinary team was comprised of physicians, psychiatrists, psychologists, 
licensed clinical social workers, substance abuse counselors, nurse practitioners, and nursing 
support staff who provided direct services to geriatric psychiatric patients in a rural outpatient 
clinic. The team included one representative from each discipline among those who were present 
and discussed any suggestions, challenges, and concerns with the group about the 
implementation of a quality improvement strategy. This team also distinguished roles for the 
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implementation of the quality improvement program and determined lines of communication to 
support improvements in medication management across disciplines. The team met once a week 
for 6 weeks.  
During the first weekly meeting, the team was asked to come together and identify 
themselves and discuss any specific skills they have that they bring to the table for resolving the 
major problem of polypharmacy for geriatric populations.  This was done as a part of the strategy 
of opening dialogues and sharing information that could improve departmental communications. 
The team then assessed the existing policies and practice guidelines of the organization in order 
to identify any deficiencies in relation to medication management and documentation systems. 
The team members identified issues and provided a rationale for any changes that were proposed 
and subsequently implemented. This meeting set the stage for group decision-making at the next 
meetings. This meeting also determined the roles of participants and set goals to be completed 
before the next meeting. These goals included seeking evidence-based practice research in 
support of any proposed changes.  
At the second and third weekly meeting, the team members discussed research, pursued 
additional research, and identified the specific policy changes proposed as extensions of the 
development process. The group discussed how effective the change initiative was in meeting the 
goals set by the group in regards to reductions in polypharmacy and improved medication 
management. I presented information derived from research and assembled a report for the group 
on the goals met by the proposed change.  
At the fourth meeting of the team, the group provided a structure for the policy changes 
and discussed how the changes would be applied in specific policy outcomes. The team also 
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related methods for integrating policy changes, including educational and informational sessions 
to be used with staff, and the implications of not implementing the changes as identified in the 
new policy guidelines (See Appendix A).  
The final meeting provided a wrap-up of the process, which included a review of the 
policy, a review of the literature pertaining to the change, and a review of instructional/ 
informational content that was shared across departments. This end meeting was the culmination 
of the first five team sessions and concluded with the production of a clear guideline and 
presentation process for integrating the change initiative in the organization (See Appendix B). 
Description of the Products 
The primary products that were created through the project and team involvement in the 
DNP project included a new set of policies related to the use of electronic medical records to be 
used as the foundation for integrating EHRs into different aspects of patient care (See 
Appendices A and B). The primary products of the DNP project included the creation of specific 
policies and practice guidelines used in the clinical setting (Appendices A and B).   The members 
of the multidisciplinary team were responsible for the creation of the primary products, and I 
provided a narrative review of these products.  Validation procedures were based on an 
evaluation of outcomes and patient data both before and after implementation. The comparative 
data was evaluated on a departmental level in order to assess areas of change and areas in which 
the change initiatives were most effective (Croll, 2010; Jha et al., 2010). This corresponded with 
existing literature about the benefits of electronic record keeping in relation to patient process 
and also related to the findings of each department about the overall level of adverse events as 
reflections of the success or failure of policy changes.   
27 
 
The secondary products include an implementation plan (Appendix C) used to assess the 
levels of polypharmacy and the nature of adverse events prior to the integration at each level of 
the organization and an evaluation plan (Appendix D) used to determine variations in the 
outcomes for patients before and after implementation of the policies and practice guidelines.  
Project team members worked collaboratively to create the policy and practice guideline changes 
and to assess levels of need for each department prior to implementation. Implementation 
practices were discussed through collaboration on departmental levels.  Each team member 
demonstrated a commitment to foster in others the same commitment to apply the initiative in 
the workplace. The validation procedures for the secondary products were based on an 
evaluation of existing literature and best practice approaches, including literature related to the 
use of technology and methods for developing policies across departments. 
Time and Resource Constraints 
This project required participation of members in the multidisciplinary team during a 6-
week period in the fall and winter of 2015.  This constraint was related both to the parameters of 
the team process and the need to complete the project in a limited span of time.  Because project 
team participants were asked to be part of the team process on a volunteer basis, there was not a 
significant budget allocated to the use of staffing resources in the hospital setting.  Subsequently, 
the project budget was limited to expenses I incurred.  
Developing Policy and Practice Guidelines 
The general policy change was integrated through the multidisciplinary team, which 
applied the change initiative that was designed to improve the quality of care by reducing 
polypharmacy. The policy specifically addressed the roles of different players at each tier of the 
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organization and has promoted the use of improved documentation systems through EHRs and a 
structured approach to care that ensured that patient prescribing information could be 
communicated to each practitioner who provided the patient with care (Croll, 2010; De Wet, 
2011; Harrington, 2011; Jha et al., 2010). The policies developed were assessed in relation to the 
evidence-based practices identified in the existing literature to determine the set of practices that 
would be used at the clinic.  
The leadership approach that I took in leading the team to successful policy development 
and implementation focused on a transformational leadership approach, which can be described 
as a style that raises leadership to the next level. Transformational leadership involves inspiring 
followers to commit to a shared vision and goals…challenging them to be innovative problem 
solvers, and developing [their] capacity via coaching, mentoring, and provision of both challenge 
and support (Bass & Riggio, 2006, p. 4).  
Transformational leadership can also be described as “the process whereby a person 
engages with others and creates a connection that raises the level of motivation and morality in 
both the leader and the follower” (Northouse, 2012, p. 186). Because of the significance of this 
issue and the need for a more effective approach to improving patient care, this leadership style 
was used to help foster a sense of commitment to the change initiative during the study process. 
Data and Participants 
The setting for this study was a rural outpatient psychiatric clinic. This setting was 
selected in order to evaluate the factors that impact the services provided for patients in this kind 
of setting and the potential implications for services orientation using a multidisciplinary team 
approach. This type of clinic was also selected because of limitations in its communication 
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modalities and its approaches to medication management in order to support the potential of a 
quality improvement program to improve services.   
The specific clinic provided support for people with a range of psychiatric disorders, 
including geriatric patients with schizophrenia, bipolar disorder, substance use disorders, and 
depression. In addition, this clinic frequently works with patients who have recently been 
released after short-stay hospital visits for psychiatric or physiological health conditions; 
referrals to the clinic were provided to improve patient outcomes after hospitalization.  
Implementation Plan Products 
I acted as the leader of the multidisciplinary team that developed a plan to be 
implemented in each department that provided directives for methods of communication and the 
use of EHRs in the rural facility. The multidisciplinary team determined which practitioners were 
responsible and had access to EHRs.  The team also determined which practitioners providing 
support services would do follow-ups, which professionals provided educational support for 
patients, and which providers were in charge of communicating with other practitioners the 
information necessary to ensure appropriate medication management.  
The policy plan and informational presentation were distributed to a number of specialists 
in the area of polypharmacy and policy development, an expert from School of Pharmacy, Yorba 
Linda University, and my preceptor, who is also an expert in the area of polypharmacy, working 
with geriatric patients, and who is an adjunct professor at USC and UCLA.  These individuals 
were selected because of their work and their specific focus on the issue of polypharmacy in 




Evaluation Plan Products 
I was responsible for assessing the outcomes of the project and my team determined what 
data were used and how they influenced assessments of the change initiative over time. The team 
also determined if information collected would be compared to national data collected from the 
current literature about the level of polypharmacy in this country, the level of polypharmacy in 
psychiatric patient populations, and the number of overall adverse events that occur as a measure 
of the success or failure of the change initiative.   
Summary 
The objectives and outcomes of this program were based on a DNP candidate-led 
multidisciplinary team that was formed to address the issue of polypharmacy in a rural mental 
health facility. The team members focused on methods to improve patient outcomes based on the 
use of electronic health records to be used to reduce polypharmacy in rural outpatient psychiatric 
clinics. This was based on the practice changes determined by the team during weekly meetings 
over a 6-week period.  
This plan for use of a DNP candidate-led team in creating a change initiative was 
recognized as a method of contributing to evidence-based practice by providing documentation 
of support for developing quality improvement methods that reduced polypharmacy. This project 
focused on a multidisciplinary approach to supporting improvements in the use of EHRs, 
attention to patient evaluation, and improved understanding of medication compliance. The 
application of the project in this area was viewed as a way of helping to defend the need for 
differentiated services in the outpatient psychiatric clinic linked to the quality improvement 
measure. This program was in response to an identified need in the clinical setting, in this case 
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the need to reduce polypharmacy for elderly patients, and the perceived benefits of the use of 
improved technologies.  
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Section 4: Findings, Discussion, and Implications 
Introduction 
For geriatric patients who frequently experience multiple comorbid physical and 
psychiatric conditions, the issue of polypharmacy is especially problematic. The use of multiple 
drugs prescribed by multiple prescribers, sometimes for the same condition, can result in adverse 
drug reactions (Hoffman et al., 2011). Polypharmacy can cause significant adverse events and 
can hinder effective treatment for elderly patients who have multifactorial health states. In the 
rural psychiatric facility, the focus of this project is the implementation of a strategic approach to 
reducing polypharmacy by improving communication and documentation methods of a range of 
providers (Slabaugh et al., 2010). The purpose of this DNP project was to create a quality 
improvement program with the aim of reducing polypharmacy in elderly patients in a rural 
outpatient psychiatric clinic. The expected outcomes of this study were to identify medications 
for each patient, increase patient knowledge, improve communications between practitioners, 
and reduce polypharmacy through the use of EHRs.  Reducing polypharmacy requires a 
commitment on the part of practitioners to support improved patient outcomes through the 
implementation of a quality improvement change initiative.  
The primary products that were developed as a part of this process included a set of 
policy and practice guidelines (Appendices A and B). The secondary products developed 
included an implementation plan (Appendix C) and an evaluation plan (Appendix D).  The 
implementation plan was developed with the goal of assessing the levels of polypharmacy and 
adverse events before a change initiative. The evaluation plan was developed to determine 
variations in the outcomes through the process of implementation of policies and practice 
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guidelines. The policy and practice guidelines were created with input from a multidisciplinary 
team to clearly identify expectations and changes. The overall results of the project included the 
creation of a multidisciplinary team, the development of a set of policies and protocols for the 
use of EHRs in the clinical setting, and the successful implementation and evaluation of the 
change initiative.   
Discussion of Project Products 
The project process required specific steps, the first of which was the creation of a 
multidisciplinary team. This team was responsible for the development of the project products, 
including the implementation and evaluation plans as well as the policy and practice guidelines 
that will dictate how the change initiative is maintained in the clinical setting over time.  These 
products provide the framework and support for the change initiative and demonstrate the 
connection between what were the practices in the facility at the time and the gaps in information 
that had to be addressed to reduce polypharmacy.  The implementation plan was created with the 
aim of evaluating the levels of polypharmacy and the impacts of adverse events in order to define 
the scope of the problem.  
The implementation plan identified the specific areas of the organization and the level of 
involvement without actually being derived from an implementation process.  These areas 
included the organizational level and departmental level. One of the most compelling statements 
made by participants in the multidisciplinary team was that there needed to be protocols and 
systems that were maintained at the organizational level and implemented at the departmental 
level, and this was demonstrated in the differentiation between the two in the implementation 
plan outline in Appendix C.  
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The implementation plan included organizational evaluations of the key access points for 
EHRs in order to determine how effective a change initiative using EHRs could be, the existing 
organizational directives for the prescribing systems already in place, and the overall problem of 
polypharmacy for the organization as a whole. In conjunction with these points, the 
implementation plan also related the need for the integration of technology-based reporting 
systems and the underlying connection between these systems and funding mechanisms for the 
mental health facility. The reflections for the organization as a whole are provided in Appendix 
E.  
From a departmental standpoint, the implementation plan took on a much more concrete 
focus and identified the level of responsibility as well as the departmental expectations for the 
use of EHRs, and it specifically noted the occupations in which participation in the change 
initiative would be mandated. This included identifying every person in each department who 
would have access to EHRs and all of the people involved in prescribing at each level of the 
organization. In order to create an impetus for acceptance of the change initiative, the focus on 
levels of polypharmacy for each was a necessary component of the implementation plan. Finally, 
the implementation plan at the departmental level also included the identification of methods 
through which technology could be expanded and individuals trained to ensure adequate use.  
An example of potential results from the departmental assessment is included in 
Appendix F. This specifically focused on the key components of the implementation plan and 
potential outcomes for the Geriatric Psychology department of the mental health facility, because 
of the prevalence of this problem for the specific population being assessed and the role of the 
department in addressing their service needs. The information provided in this implementation 
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plan addressed the specific needs of the department in terms of overall prescribers, access point 
needs, and the problems that relate specifically to how polypharmacy is assessed, including in-
take information and its impacts.  
The evaluation plan provided in Appendix D outlined the variations in the outcomes 
through the process of implementing policies and practice guidelines. The organizational rubric 
set out the parameters for assessing planning, initiation, strategic implementation, policy 
assessment, and successful outcomes in relation to the different aspects of the problem: 
communication, polypharmacy, and adverse events. One of the notable elements regarding 
communications in the interdisciplinary team was that adverse events were not reported as 
concretely as they should have been. One nurse practitioner maintained that not all adverse 
events that were likely impacted by polypharmacy were described that way in the evaluation or 
treatment process, and so were not always indicated in data collected about the level of impact 
on a department.  
The project focused on the planning and development process, and so outcomes of the 
implementation and evaluation were not a part of this project. Members of the multidisciplinary 
team reflected on how they perceived the implementation and evaluation plan processes to 
evolve, and this information is provided in Appendices E, F, and G.  
The policy guidelines outlined in Appendix A were the foundation for the change 
initiative and were clearly identified by the multidisciplinary team as the foundation for the 
changes that occurred. These represent the end product, and modifications were not made to 
these policies after they were finalized. The policies included the use of EHRs for patient 
documentation, the use of EHRs across departments, the use of technology to support accuracy 
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in record keeping, the identification of privacy approaches that are in alignment with HIPAA to 
diminish breaches of privacy from multiple access points, and the use of educational systems in 
the mental health facility to improve overall integration of technology. Multidisciplinary team 
members worked collaboratively to create the policy and practice guideline changes and to 
assess levels of need for each department prior to implementation. Implementation practices 
occurred through collaboration on departmental levels.  Each team member demonstrated a 
commitment to the process of change and fostered commitment in others to apply the change 
initiative to the workplace process.  
The outcomes of this project reflected the views of team members about the connection 
between communication modalities and the approaches to maintaining accurate records for 
geriatric patients, specifically with the aim of reducing polypharmacy. For geriatric patients who 
have multiple comorbid conditions, polypharmacy is becoming increasingly common when 
communication between practitioners is inadequate (Hoffman et al., 2011). Members of the 
multidisciplinary team maintained that even though their facility was relatively small, 
communications did not occur on a regular basis to support the accuracy of patient care plans in 
reflecting the prescribing practices for each patient. This corresponds with the findings of 
researchers including Slabaugh et al., (2010), who argued that polypharmacy for elderly patients 
is exacerbated by the fact that there are multiple states of health that may be treated by a range of 
practitioners, resulting in medication regimens that overlap. For example, Bilyeau et al., (2011) 
maintained that conditions like depression may be treated by multiple practitioners, including a 
psychiatrist and a general practitioner, seeing the same symptoms in a patient.  
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One of the challenging aspects of creating the plan and identifying approaches to change 
within the multidisciplinary team was settling on a definition of the problem of polypharmacy. 
The team settled on creating a definition and reflecting the need for intervention based on the 
belief that polypharmacy can be seen as the concurrent use of multiple drugs for the treatment of 
the same clinically indicated illness as well as the presence of inappropriate drug use or the use 
of multiple drugs in a manner that is ineffective, excessive, or can result in adverse events (Viktil 
et al., 2007).  
The most significant measurable outcomes sought in this project were the demonstration 
of a reduction in polypharmacy from current levels to no incidences after implementation of the 
multidisciplinary team-initiated EHR project. Though this was clearly an aim of the process, the 
details identified in Appendices E, F, and G reflected projected views of what could occur when 
implemented. This was based on the assertion that no level of polypharmacy would be 
acceptable in the clinical setting and that EHRs should trigger a report when multiple prescribers 
enter data about patient process into the system. One of the key tracking elements of this 
operation involves the constant use of updated material and ready access to the EHR system. 
Members of the multidisciplinary team questioned the methods for implementation that could 
occur through the application of the project and the impact for project outcomes.  Participation 
and compliance with EHR use is imperative in any facility where the project is implemented 
because of the mechanisms involved in ensuring that polypharmacy does not occur. The EHR 
system identifies when three or more medications are being prescribed for an individual patient 
for a single condition or when overlapping prescriptions have been produced by multiple 
providers. When the EHR notifies the prescribing professional of the presence of polypharmacy 
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during the chart update process, the practitioner has a number of opportunities to contact the 
other professional or assess the orders that exist for the patient in order to make necessary 
corrections to avoid polypharmacy. Even in light of these protocol changes and the policy 
development, members of the multidisciplinary team maintained that errors may still occur even 
after implementation of the EHR system.  
In the evaluation of outcomes related to the DNP project, I took on a number of roles, 
including the leader of the multidisciplinary team and the liaison between each department and 
the team itself. The team focused on the creation of the policy plan and also provided narrative 
information about any problem, its potential solutions, and major areas of concern in relation to 
the use of EHR systems and the training protocols needed for successful implementation. I was 
also responsible for assessing the outcomes of the project and for integrating narrative data and 
specific resources to determine if practitioners believed polypharmacy might continue once the 
plan is implemented. 
Implications 
Policy  
The change initiative developed in this DNP project has a number of implications for 
policy, practice, research, and social change. The general policy change was integrated through 
the multidisciplinary team to apply the change initiative designed to improve the quality of care 
for the geriatric patients being served in the mental health facility. As a result, the policy change 
was in alignment with the goal and it reflected an evidence-based approach (Croll, 2010; De 
Wet, 2011; Harrington, 2011; Jha et al., 2010). Subsequently, the DNP project resulted in policy 




The policy changes also determined specific practice changes, including changes in the 
way communications occur across departments and in the approaches used to document patient 
process. The use of EHRs was the defining element in this practice change, and it led to 
significant alterations in communication systems and approaches to care. Increasingly, the team 
approach for creating the policies reflected a greater need for such team approaches in providing 
patient care. Because of the significance of this issue and the need for a more effective approach 
to improving patient care, this focus of this process resulted in improved function in the facility 
as a whole. 
Research 
In this research, I identified provided a foundation for policy changes and demonstrated 
the application of best-practice approaches related to research evidence. Current studies on the 
changing nature of the elderly population, increasing issues with medication management, and 
the need for better methods of communication are all a part of the review of literature provided 
(Cefalu, 2006; Greenawalt, 2009; Hoffman et al., 2011; Hogan & Kwan, 2006; Hutchinson, 
2008; Porter & Kaplan, 2012; Trivalle et al., 2010; Viktil et al., 2007). Research has indicated 
that polypharmacy was a significant problem that had to be addressed through the policy changes 
(Langan & Shajahan, 2010; Tiihonen et al., 2012; Zink et al., 2010). Existing research has 
supported the value of the use of technology and the use of patient support mechanisms to reduce 
the chances of polypharmacy that result in adverse events (Langan & Shajahan, 2010). These 
elements were clearly identified in the change initiative for the facility.  
Social Change  
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The change initiative and policy decision-making also reflected the importance of 
improving outcomes as a social change strategy. The overall problem of polypharmacy has a 
significant impact on populations as a whole, and this project sets the tone for increasing use of 
technology in rural settings to improve patient outcomes (Trivalle et al., 2010). Correspondingly, 
the importance of creating mechanisms through which communications can advance to improve 
patient outcomes was also clearly demonstrated in this project. Both of these elements support 
social change because they improve outcomes for patients while addressing the need for 
improvements in a variety of different settings.  
Dissemination of the Project 
The implications for both research and social change require the dissemination of this 
project to other professionals who can benefit from the information presented. As a result, this 
DNP project will be presented in informal nursing settings in mental health facilities and at a 
conference on mental health nursing.     
Strength and Limitations of the Project 
This study provided an accurate reflection of the range of different ways in which EHRs 
can be used to ensure medication use is in alignment with patient needs, and the use of data from 
a facility and a multidisciplinary team are both strengths of this project. One of the weaknesses is 
that this project did limit the focus to the application in a single rural facility and so the outcomes 
cannot fully be understood if applied in other settings.  
Analysis of Self 
As a DNP candidate, I recognized the importance of accurate and adequate 
communication in the care of patients and also sought methods to ensure that this could occur in 
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rural settings where practitioners may be spread out over different facilities. My focus was to 
ensure that communication could occur and that medication management was as accurate as 
possible through the use of new technologies. I sought this information and used a 
multidisciplinary team approach to developing protocols for its use in the rural mental health 
facility. The policy development process required a leader for the multidisciplinary team and I 
became this leader, employing a variety of leadership techniques and fostering beneficial 
communication in the group through a transformational leadership model. Transformational 
leadership involves inspiring followers to commit to a shared vision and goals, “…challenging 
them to be innovative problem solvers, and developing [their] capacity via coaching, mentoring, 
and provision of both challenge and support” (Bass & Riggio, 2006, p. 4). This was my focus 
during the process, and I used a range of strategies during the team process to realize applicable 
change. I gained a significant amount of insight into the development of policy through the 
discourse about policy process and also recognized the variety of stakeholders who can be 
involved and the different stakeholder interests that are reflected when discussions about policy 
process occur.  
As a practitioner, scholar and project manager, I found that the two elements are 
intertwined when exploring major policy changes in the clinical setting. The stakeholders 
involved in the process of change frequently require a broad range of information supporting a 
change initiative, and solid leadership requires a rationale for change in order to challenge 
resistance. The use of the team approach had significant benefits in addressing stakeholder 
concerns and in creating an effective method for communicating both the need for change and 
the approaches to best address change in each department.  
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The long-term goals for myself as a practitioner, scholar, and project manager include 
some of the same elements: to maintain a consistent message, to demonstrate understanding of a 
range of perspectives, to strive for greater knowledge, and to enact effective change. 
Recognizing that nursing is a dynamic profession requiring continuous change and constant 
awareness of stakeholder interests should be a foundational element in driving nursing research. 
After this DNP project was completed, I recognized my need to constantly assess the best 
approaches in nursing care and to determine strategic approaches through the application of 
effective research.  
Summary 
Research clearly indicates that polypharmacy is particularly problematic in geriatric 
patients and in psychiatric populations as a whole (Langan & Shajahan, 2010; Tiihonen et al., 
2012; Zink, Englisch, & Meyer-Lindberg, 2010). There is increasing evidence that effective 
communication and effective medication management go hand-in-hand, and this project 
provided additional support for this assertion. Communication and management systems that are 
technology-based, including the use of electronic health records (EHRs) provide a foundation for 
communications between varied practitioners in the rural mental health facility and can help to 
reduce the level of polypharmacy.  
The aim of this DNP project was to create a quality improvement program for reducing 
polypharmacy in elderly patients in a rural outpatient psychiatric clinic. The multidisciplinary 
team created and supported a policy change and new technologies.  This information suggests 
the need for continued study of the impacts of EHRs in the clinical setting and continued 
research into the best approaches to reducing adverse events from poor medication management.  
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Section 5: Scholarly Product 
Abstract 
Adequate medication management should be a focus of effective care for patients, but can often 
be overlooked in caring for adults with comorbid psychiatric and physical conditions. This is 
especially true when patients see multiple care providers and when they have a variety of health 
issues that are being treated at the same time.  The purpose of this DNP project was to create a 
quality improvement program with the aim of reducing polypharmacy in elderly patients in a 
rural outpatient psychiatric clinic. The theoretical foundations are based on Bandura’s (1997) 
self-efficacy theory used to assess a person’s motivation, capacity for self-regulation, and 
perceptions regarding individual ability to meet particular end goals. The goals of this project 
included creating a multidisciplinary team to explore the best approaches to implementing 
electronic health records (EHR) in a rural mental health facility, and creating a policy change and 
educational program to implement the new plan developed by the multidisciplinary team.  The 
multidisciplinary team successfully developed a protocol and educational plan for nursing staff 
to apply to the use of EHRs to prevent polypharmacy in the rural psychiatric outpatient setting. 
This project led to the creation of protocols for the introduction of an electronic health record 
(EHR)-based approach to patient medication management supported by professionals from a 
range of fields. This project utilized a multidisciplinary team to explore the best approaches for 
implementing an EHR-based approach. The major products for this project included the 
multidisciplinary team, the plan for integrating medical records and assessments through EHRs, 
and the specific practice guidelines. The problem of polypharmacy is becoming increasingly 
common in older adults, and poses a threat to individuals in rural settings.  Developing methods 
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and strategies to improve patient outcomes and reduce adverse events is becoming a necessary 
component of care for elderly patients. 
Program Evaluation Report 
The preliminary outcomes of the evaluation plan after an initial period of implementation 
reflected interesting perspectives on the impacts of each stage of the process. These preliminary 
results were reflected in documentation provided in Appendix G. The results included here 
integrated both the views of the strategic process and the steps through which changes were 
made in relation to improving communication and reducing both polypharmacy and adverse 
events. This included relating whether successful outcomes were achieved. Though the aim was 
to reduce polypharmacy so that zero adverse events would occur, this goal was not achieved as a 
part of the change initiative. Continued participation in the policies and approaches outlined 
would determine the continued movement towards this aim over time.   
Problem 
Adequate management of patient medication regimens can be a difficult component of 
care, primarily because many practitioners rely on reports of patients about their medications, 
both prescribed and over-the-counter, in order to determine the need for additional medications 
or if adverse interactions might occur. This results in the problem of polypharmacy, which Viktil 
et al., (2007) described as “the concurrent use of multiple drugs, [or]…the use of more drugs 
than are clinically indicated or too many inappropriate drugs” (p. 187). Hoffman et al., (2011) 
maintained that this can sometimes reflect an imprecise view of the overall problem in relation to 
psychiatric patients, and they more clearly defined polypharmacy for this population as the use 
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of two or more medications in the same patient to treat the same condition, or the use of two or 
more of the same chemical class of medications used to treat the same psychiatric ailment.  
For geriatric psychiatric patients, who often have multiple comorbid psychiatric and 
physical conditions, polypharmacy can result from the use of multiple psychiatric drugs, multiple 
prescribers, and/or the use of drugs that result in adverse drug reactions because of the lack of 
continuity in communications regarding overlapping medication regimens (Hoffman et al., 
(2011). Slabaugh et al., (2010) maintained that polypharmacy can complicate the treatment 
process for elderly patients who have multifactorial health states and require medications for 
psychiatric conditions. In addition, one of the problems for elderly populations is that medication 
regimens may become less effective over time, resulting in the perceived need for additional 
medications, especially in the treatment of psychiatric conditions (Bilyeu et al., 2011).  
Purpose 
The purpose of this DNP project was to develop a quality improvement program with the 
aim of reducing polypharmacy in elderly patients in a rural outpatient psychiatric clinic. This 
quality improvement program focused on three specific areas designed to reduce polypharmacy: 
1-identifying all medications, prescribed and over-the-counter, utilized by each patient; 2- 
increasing patient understanding of the purpose and side effects of each medication; and 3- 
improving communications among practitioners to reduce the opportunities for polypharmacy. 
The focus of this program was the incorporation of new policies and systems in a 





Goals and Outcomes 
The most significant goal of this project was to introduce a new approach to 
systematically addressing the issue of polypharmacy with the aim of reducing the problem in 
elderly populations receiving treatment in a rural psychiatric outpatient clinic. The goal of 
creating the project to reduce polypharmacy required the ability to assess current perspectives on 
changing the present system and the level of commitment that individuals have to improving 
patient outcomes through the implementation of the project. 
The overall approach to developing a multidisciplinary team method was to address the 
problem of polypharmacy based on the need for effective collaborative policies, leading to the 
creation of a multidisciplinary team to develop a quality improvement program based on EHR 
technology to reduce polypharmacy. The team included a range of different institutional 
stakeholders and individuals responsible for prescribing medication for this population.   
Significance for Future Practice, Research, and Social Change 
Elderly populations seeking treatment in rural psychiatric outpatient clinics may have a 
long history of psychiatric disorders and demonstrate problems that range from effective 
adherence to medication regimens to the need for periodic and/or systematic changes in 
medication that can impact the level of control over the psychiatric disorder (Greenawalt, 2009; 
Hoffman et al., 2011; Hogan & Kwan, 2006). For example, an elderly patient may have 
experienced years of well-controlled bipolar disorder and may find that he or she is suddenly 
experiencing symptoms. This patient may be treated by one or more practitioners, who may 
prescribe a range of medications to treat the symptoms. Changes in physiological processing of 
medication and changes in the levels of response to a medication may result in a variety of 
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different views on the best treatment modalities for the patient. In addition, the presence of 
comorbid health conditions and medications can result in polypharmacy that has a negative 
impact on the patient’s psychiatric and physical condition.  
Most practitioners reflect on the patient’s history, including prescribing history, as a part 
of their evaluation of the need for new medications (Hutchinson, 2008). At the same time, a 
focus on patient self-reports of medication and the present use levels for medication does not 
always reflect a full and complete assessment of the medication regimen. Subsequently, 
practitioners need to determine more effective strategies for gaining insight into patient 
medication use, medication regimens prescribed, and the potential for adverse events each time a 
patient presents in the rural psychiatric outpatient clinic.  
The significance of the project related directly to the increase in the number of elderly 
patients seeking services, the increasing need for effective medication management, and the 
noted number of adverse events that were occurring as a result of medication mismanagement. 
The increase in our aging population is ongoing: There were approximately 40 million people 
living in the United States over the age of 65 in 2010, which comprised about 13% of the 
population (FIFARS, 2012); that number will jump to over 72 million in 2030 to comprise about 
20% of the population (FIFARS, 2012). 
Literature and Evidence 
There are distinct physiological and psychological changes that occur with age. Elderly 
adults experience changes that impact how medications are processed, and this can change 
expected outcomes of medications. Specifically, bioavailability can be impacted by age, and this 
is reflective of changes that correspond with aging, including weight gain, changes in excess fat 
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deposition, and changes in GI processing, increased levels of stress, and decreased levels of 
physical activity (Porter & Kaplan, 2012). As people age, their metabolism of medications can 
slow, which corresponds both with a general slowing of metabolism and the impacts of physical 
condition, all of which require adjustments to drug interventions or therapies that are being used 
for elderly patients. 
Patients aged 65 and older often experience suboptimal pharmacotherapy, primarily 
because of changes in drug metabolism, target organ sensitivity, problematic drug interactions, 
and even drug toxicity (Trivalle et al., 2010). Commonly, these changes result in longer periods 
of drug activity, which can have a greater or lesser drug effect and an increased level of potential 
toxicity resulting from metabolic changes (Trivalle et al., 2010). 
While the current literature reflected the nature of this problem in regards to psychiatric 
patients in clinical settings, the assumption that these individuals were uninvolved in their 
medication management was a general misperception that was recognized by researchers, 
including Mizokami et al., (2012) and Munger (2010). Literature has indicated that 
communications and effective medication management is a cooperative element requiring 
compliance, support, and regular assessments in order to reduce the chances of problematic 
medication mismanagement (Tiihonen et al., 2011).  Existing literature has maintained the 
importance of the use of technology and the use of patient support mechanisms to reduce the 
chances of polypharmacy that results in adverse events (Langan & Shajahan, 2010). 
Suokas et al., (2013) conducted a large nationwide study to determine the prevalence and 
potential predictors of long-term polypharmacy specific to patients receiving treatment for 
schizophrenia. This project specifically focused on the impacts of antipsychotic polypharmacy in 
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patients and reflected on those who had experienced at least one hospitalization for 
schizophrenia during the study period (Suokas et al., 2013). The researchers conducted a cohort 
study defined by the presence of hospitalization for schizophrenia between 2000 and 2007 in 
order to determine if antipsychotic polypharmacy had occurred. Because of the precarious nature 
of treatment modalities for patients with schizophrenia, these researchers identified the problem 
of polypharmacy simply as patients being prescribed two or more overlapping prescriptions for 
different antipsychotics in a 60-day period (Suokas et al., 2013). They found that patients with 
schizophrenia and antipsychotic polypharmacy were at an unacceptable level, with more than 
46% of patients experiencing this problem. In addition, the researchers posited that there were 
implications that this kind of prescribing mismanagement of patients with schizophrenia can lead 
to the need for hospitalization. 
Cefalu (2006) maintained that while this predisposition to adverse reactions occurs in 
populations over the age of 65, the most problematic outcomes of these reactions occur in 
patients over the age of 85, who can take an average of 5 to 8 drugs each day. “A number of 
reports have shown that the risk of adverse drug events in elderly patients rises with comorbidity; 
increasing numbers of medications; inappropriate medications; the use of antipsychotics, 
anticoagulants, diuretics, and antiepileptics; and the use of multiple prescribers and pharmacies 
by patients and caregivers” (Cefalu, 2006). The use of a patient profile and pharmacology 
questionnaire should occur at each visit, including an identification of any alternative treatments 
or supplements that could interfere with the function of other drugs. Sharing this information 
through the use of electronic health records was identified as the program approach best suited to 
reduce polypharmacy and improve patient outcomes.  
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Literature specific to the issue of polypharmacy in elderly patients with psychiatric 
disorders related to the connection amongst changing psychiatric medications, changing patient 
needs, and comorbid conditions that exist for elderly patients, all of which can increas the risk of 
polypharmacy. This specific project provided a foundation for understanding the overall problem 
and could subsequently be applied to scrutinize the process at a rural outpatient psychiatric 
clinic.  
Interdisciplinary Teams 
Implementing a multidisciplinary approach to reducing polypharmacy required an 
assessment of current systems, the creation of recommendations from the multidisciplinary team 
for change, and the views of practitioners about their commitment to reducing the problem of 
polypharmacy through program implementation. This was completed within the team process as 
components of the DNP project. The DNP candidate acted as the leader of the multidisciplinary 
team. The project sought to demonstrate reduction in polypharmacy from current levels to no 
incidences after implementation of the multidisciplinary team-initiated EHR project planned by 
this DNP candidate.  
The DNP candidate developed a multidisciplinary team from selected from different 
departments and set the goal of creating policies and practice guidelines to reduce polypharmacy.  
After selection, the multidisciplinary team explored studies on the use of EHRs in reducing 
medication polypharmacy and adverse events caused by medication errors (Croll, 2010; Jha et 
al., 2010).  This information was then used in the development of policies and practice 




After these policies were developed, the information was shared with scholars in the field 
to validate the content of the policies and practice guidelines. This provided a foundation for 
assessing the mechanisms for change in alignment with their views of evidence-based 
approaches. The project team developed an implementation plan for these polices and methods 
for evaluating the outcomes of the policies (See Appendices C and D).  The outcomes of the 
development process included recognition that the approach provided a cost-effective method of 
change that could improve patient outcomes and the quality of care. 
This included the strategies for the application of the set of proposed policies in rural 
mental health facilities. Because no level of polypharmacy is acceptable and because of the 
severity of adverse reactions for the elderly population studied, the use of electronic health 
records as a change protocol should aim for reduction to zero events after implementation of the 
program planned in this project.  The policies and practice guidelines and methods of evaluating 
their effectiveness were developed as a part of the multidisciplinary team approach. 
1. The DNP candidate acted as the leader of a multidisciplinary team created to develop a 
quality improvement program based on EHR technology to reduce polypharmacy. The team 
included a range of different institutional stakeholders, with individuals responsible for 
prescribing medication for this population. As a result, the researcher was responsible for 
selecting and integrating members of the multidisciplinary team in the development of policies 
and protocols to reduce polypharmacy; 
2. The DNP candidate led the multidisciplinary team in exploring studies on the use of 
EHRs to reduce medication polypharmacy and adverse events caused by medication errors 
(Croll, 2010; Jha et al., 2010).  
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3. The project team, led by the DNP candidate, developed policy and practice guidelines. 
4. The DNP candidate validated the content of policies and practice guidelines by sharing 
the information with scholars in the field. This provided a foundation for assessing the 
mechanisms for change in alignment with their views of evidence-based approaches.  
5. The project team, led by the DNP candidate, developed an implementation plan and an 
evaluation plan (See Appendices C and D) 
6. This approach provided a cost-effective system for creating a change initiative because it 
engaged the work of the DNP candidate to lead the team and create the plan.  
Discussion and Implications 
The outcomes of this project reflected the views of team members about the connection 
between communication modalities and the approaches to maintaining accurate records for 
geriatric patients, specifically with the aim of reducing polypharmacy. For geriatric patients who 
have multiple comorbid conditions, polypharmacy is becoming increasingly common when 
communication between practitioners is inadequate (Hoffman et al., 2011). Members of the 
multidisciplinary team maintained that even though their facility was relatively small, 
communications did not occur on a regular basis to support the accuracy of patient care plans in 
reflecting the prescribing practices for each patient. This corresponds with the findings of 
researchers including Slabaugh et al., (2010) who argued that polypharmacy for elderly patients 
is exacerbated by the fact that there are multiple states of health that may be treated by a range of 
practitioners, resulting in medication regimens that overlap. The primary and secondary products 
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of this project demonstrate the progression towards this goal through the development of the 
team approach and the identification of potential policy and guideline changes.  
Primary Products 
The primary products created through the team’s involvement in the DNP project 
included a new set of policies related to the use of electronic medical records, which created the 
foundation for integrating EHRs into different aspects of patient care (Appendices A and B). In 
addition to establishing new policies, the primary products of the DNP project included the 
creation of practice guidelines used in the clinical setting (Appendices A and B).  
Secondary Products 
The secondary products included an implementation plan (Appendix C) used to assess the 
levels of polypharmacy and the nature of adverse events prior to the integration at each level of 
the organization. It also included an evaluation plan (Appendix D) utilized to determine 
variations in the outcomes for patients before and after implementation of the policies and 
practice guidelines. Project team members worked collaboratively to create the policy and 
practice guideline changes and to assess levels of need for each department prior to 
implementation. Implementation practices were outlined through collaboration on departmental 
levels.  Each team member demonstrated a commitment to the process of change and fostered 
commitment in others with the view of one day applying the change initiative to the workplace 
process.  
Summary 
Research clearly indicates that polypharmacy is particularly problematic in geriatric 
patients and in psychiatric populations as a whole (Langan & Shajahan, 2010; Tiihonen et al., 
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2012; Zink, Englisch, & Meyer-Lindberg, 2010). There is increasing evidence that effective 
communication and effective medication management go hand-in-hand, and this research project 
provided additional support for this assertion. Communication and management systems that are 
technology-based, including the use of electronic health records (EHRs), could provide a 
foundation for communications among varied practitioners in the rural mental health facility to 
help reduce the level of polypharmacy.  
The aim of this project was to create a quality improvement program for reducing 
polypharmacy in elderly patients in a rural outpatient psychiatric clinic. The policy changes 
produced in this project were designed to ensure reductions in polypharmacy and support 
measures for improved quality. These perspectives were seen through narrative data on a 
departmental level that supports the continued development of this kind of change protocol. This 
information suggests the need for continued study of the impacts of EHRs in the clinical setting 
and continued research into the best approaches to reducing adverse events due to poor 
medication management. 
Dissemination Project 
My DNP project was based on the identification of polypharmacy as a significant 
problem for health care practitioners and nursing staff in psychiatric hospitals. As the DNP 
project coordinator, I sought methods to reduce polypharmacy for this population and pursued 
research-based methods to improve patient outcomes. The specific focus of this project was to 
bring together a multidisciplinary team to create a set of policies and guidelines to be used for 
the implementation of electronic health records as a standard of care to reduce polypharmacy in a 
rural mental health facility.   
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Polypharmacy in populations of adults age 65 or older is a significant issue, especially in 
populations receiving care in mental health facilities. This evidence-based research project 
assessed the problem of polypharmacy from a variety of perspectives, provided a definition for 
polypharmacy for this specific population, and proposed a method that was preliminarily 
implemented to create greater accountability in addressing the needs of an aging population 
through the use of electronic health records (EHRs). This project was developed to change the 
way in which healthcare professionals address the needs of their patients in rural health clinics, 
which includes assessing their medication needs and seeking information, through the use of 
improved technologies, that can prevent polypharmacy in this vulnerable population. 
Problem 
This project is based on the belief that adequate management of patient medication 
regimens can be a difficult component of care, but only through doing so can practitioners ensure 
the safety of their patients.  The problem of polypharmacy is a significant one that impacts 
elderly psychiatric populations more than any other single population (Slabaugh et al., 2010).  
For geriatric psychiatric patients who often have multiple comorbid psychiatric and physical 
conditions, polypharmacy can result from the use of multiple psychiatric drugs, multiple 
prescribers, and/or the use of drugs that result in adverse drug reactions because of the lack of 
continuity in communications regarding overlapping medication regimens (Hoffman et al., 
2011).  
Purpose 
The purpose of this DNP project was to develop a quality improvement program with the 
aim of reducing polypharmacy in elderly patients in a rural outpatient psychiatric clinic. This 
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quality improvement program focused on the creation of policies and guidelines by a 
multidisciplinary team to implement the use of EHRs in reducing polypharmacy.  
Goals and Outcomes 
The overall approach to developing a multidisciplinary team method was to address the 
problem of polypharmacy based on the need for effective collaborative policies. This entailed the 
creation of a multidisciplinary team to develop a quality improvement program, as well as 
policies and guidelines based on EHR technology to reduce polypharmacy. The team included a 
range of different institutional stakeholders, including individuals responsible for prescribing 
medication for this population. 
Significance 
The significance of the project related directly to the increase in the number of elderly 
patients seeking services, the increasing need for effective medication management, and the 
noted number of adverse events that occur as a result of medication mismanagement. There were 
approximately 40 million people living in the United States over the age of 65 in 2010, which 
comprises about 13 percent of the population (FIFARS, 2012). That number will jump to over 72 
million in 2030, increasing to about 20 percent of the population (FIFARS, 2012). 
Literature and Evidence 
Patients aged 65 and older often experience suboptimal pharmacotherapy, primarily 
because of changes in drug metabolism, target organ sensitivity, problematic drug interactions 
and even drug toxicity (Trivalle et al., 2010). Commonly, these changes result in longer periods 
of drug activity, which can have a greater or lesser drug effect, and an increased level of 
potential toxicity resulting from metabolic changes (Trivalle et al., 2010). 
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Existing literature maintained the importance of the use of technology and the use of 
patient support mechanisms to reduce the chances of polypharmacy that results in adverse events 
(Langan, & Shajahan, 2010). Literature specific to the issue of polypharmacy in elderly patients 
with psychiatric disorders related to the connection amongst changing psychiatric medications, 
changing patient needs, and comorbid conditions that exist for elderly patients, all of which can 
increase the risk of polypharmacy. This specific project provided a foundation for understanding 
the overall problem and could subsequently be applied to scrutinize the process at a rural 
outpatient psychiatric clinic. 
The Team 
Implementing a multidisciplinary approach to reducing polypharmacy required an 
assessment of current systems, the creation of recommendations for change by the 
multidisciplinary team, and the views of practitioners about their commitment to reducing the 
problem of polypharmacy through program implementation. This was completed within the team 
process as components of the DNP project. The project sought to demonstrate reduction in 
polypharmacy from current levels to no incidences after implementation of the multidisciplinary 
team-initiated EHR project planned by this DNP candidate.  
Discussion and Implications 
The outcomes of this project reflected the views of team members about the connection 
between communication modalities and the approaches to maintaining accurate records for 
geriatric patients, specifically with the aim of reducing polypharmacy. For geriatric patients who 
have multiple comorbid conditions, polypharmacy is becoming increasingly common when 




The primary products that were created through the project and team involvement in the 
DNP project included a new set of policies related to the use of electronic medical records to be 
used as the foundation for integrating EHRs into different aspects of patient care (Appendices A 
and B). The primary products of the DNP project included the creation of specific policies and 
practice guidelines used in the clinical setting (Appendix A and B).  
Secondary Products 
The secondary products included an implementation plan (Appendix C) used to assess the 
levels of polypharmacy and the nature of adverse events prior to the integration at each level of 
the organization and an evaluation plan (Appendix D) utilized to determine variations in the 
outcomes for patients before and after implementation of the policies and practice guidelines. 
Project team members worked collaboratively to create the policy and practice guideline changes 
and to assess levels of need for each department prior to implementation. Implementation 
practices were outlined through collaboration on departmental levels.  Each team member 
demonstrated a commitment to the process of change and fostered commitment in others with the 
view of one day applying the change initiative to the workplace process.  
Summary 
Research clearly indicates that polypharmacy is particularly problematic in geriatric 
patients and in psychiatric populations as a whole (Langan & Shajahan, 2010; Tiihonen et al., 
2012). There is increasing evidence that effective communication and effective medication 
management go hand-in-hand, and this research project provided additional support for this 
assertion. Communication and management systems that are technology-based, including the use 
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of electronic health records (EHRs) could provide a foundation for communications between 
varied practitioners in the rural mental health facility and help to reduce the level of 
polypharmacy.  
The aim of this DNP project was to create a quality improvement program for reducing 
polypharmacy in elderly patients in a rural outpatient psychiatric clinic. The policy changes 
produced in this project were designed to ensure reductions in polypharmacy and support 
measures for improved quality. These perspectives were seen through narrative data on a 
departmental level that supports the continued development of this kind of a change protocol. 
This information suggests the need for continued study of the impacts of EHRs in the clinical 
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Appendix A: Policy Final Product 
Purpose: Following are the central components of the policy’s purpose: 
• To establish a set of guidelines for the use of electronic health records (EHRs) in the rural 
health care facility; 
• To create the parameters by which EHRs will be used to ensure the accuracy of patient 
prescribing, thus reducing medication errors; 
• To meet medical records compliance requirements set forth by the Federal and State 
Laws; 
• To ensure the confidentiality of every patient. 
 
Scope: This policy applies to all employees and management of the rural mental health facility 
across all departments, including any practitioners contracted to work on behalf of the facility.  
 
Responsibility: Physicians, nursing staff, mental health practitioners, clinicians, and medical 
records/billing staff at the rural mental health facility.  
 
Policy: The rural mental health facility will ensure the maintenance and protection of health 
records in alignment with legal requirements. After implementation, each patient will participate 
in an in-take interview that will include a review and documentation in EHR of all medications 
and OTC products utilized by the patient, in addition to health status updates. EHRs will be used 
to ensure the adequate sharing of technology-based patient information to support appropriate 
care; the use of the EHR by practitioners with licensure to prescribe medications, including 
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access to and review of patient EHR prior to prescribing any medication; the entering of 
prescribed medications, and the review of any flags that occur prior to distributing medications 
to a patient; the documentation of any subsequent medication conflicts; practitioner-to-
practitioner communications; and changes made to prescribed medications or medication 
management plans in the EHR.  
 
Confidentiality: All personnel who have access to patient protected health records must sign a 
Confidentiality Agreement that assures the privacy of password and patient information, and the 
protection of access points. Access to EHRs will be protected in accordance with HIPAA 
regulations in regards to the retrieval, availability, accessibility and confidentiality of personal 
patient information.  
 
Patient Referral and Tracking: EHRs will also be utilized to support increased communication 
during patient referral or transfer to other mental health facilities or practitioners, and this 
includes managing EHR operations in real-time to maintain the immediacy and accuracy of 
patient information as they move between practitioners. 
Reference 





Appendix B: Practice Guidelines 
The practice guidelines for the rural health care facility are based on two specific aims: 1. To 
create a systems-oriented approach to maintaining the safety of all patients, and 2. To create a 
safe environment within which all patients can work towards their personal goals by recognizing 
the errors, their causes, and a strategic approach for change. Following are the guiding points for 
practice:  
1. Adopt the use of EHRs as a part of a systems approach to reducing medication errors in 
the rural mental health facility;  
2. Utilize EHRs as a means of systematically documenting patients at each stage of their 
treatment, including their intake, assessments, medication management, outtake, and 
referral or transfer.  
3. Maintain the confidentiality of each practitioner accessing patient care. 
4. Utilize EHRs to ensure that reporting mechanisms are updated in real-time and can 
support communication across departments.  
5. Provide physicians, clinics, nursing professionals, and others involved in medication 
administration with the skill they need to effectively assess patient condition, identify red 
flags, and use technology as a basis for communication with other practitioners providing 
care.  
6. Support the use of EHRs in every department in the organization. 





Adopting EHRs to Reduce Mediation 
Management 
Nursing staff will document EHRs at intake and the 
information will be used by physicians, nurse 
practitioners and other professionals with 
prescribing licensure to make medication 
management decisions.  
Systematic Documentation at Each Patient 
Stage 
 
Any mental health professionals working directly 
with patients will access and update EHRs 
whenever treatment is provided. Documentation will 
include: updating medication information, relating 
OTC medication use, relating significant alterations 




The Privacy Rule provides that an individual has a 
right to adequate notice of how a covered entity may 
use and disclose protected health information about 
the individual, as well as his or her rights and the 
covered entity’s obligations with respect to that 
information (HIPAA, 2003). Because a variety of 
access points exist for the EHR technology, the 
Privacy Rule will be applied to protection of patient 
information at remote locations. Passwords will be 
identified through a generated system and clinicians 
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All health professionals will document their 
interactions with patients and any alteration of 
patient information while working directly with the 
patient. The person-to-person sharing of information 
in real time is based on the importance of this 
information that is needed for change.  
Prescribing Professional Process 
 
The following process will be followed: 
Review of EHR information; 
Input of new patient information; 
Update of medication management plan; 
Identification of new prescription; 
Input of new prescription;  
Evaluation of any red flags; 
Communication with other prescribing 
professionals, when needed; 
Subsequent update of any new or changing 
prescribing plan.  
Training 
 
Two mandatory training programs will be conducted 
prior to use of the new system. Key components of 
the training program will include the 
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rationale/purpose of the approach, the systematic 
approach to be utilized, methods for evaluating the 
outcomes, assessments and communications utilized 
between practitioners, and the importance of real-





Appendix C: Implementation Plan 
 The implementation plan was developed with the goal of assessing the levels of polypharmacy and the nature of adverse 
events prior to the integration at each level of the organization.  
 
 EHR Access Points Prescribing Systems Levels of Polypharmacy Reporting Systems 
Organizational Identify key access 
points and determine 
which departments will 




directives to determine 
the application of EHR 
systems for 
practitioners 
responsible for patient 
prescribing. 
Identify the nature of the 
problem for the 
organization as a whole 
through reporting systems 
and the identification of 
polypharmacy in patient 
populations.  
Integrate technology-based 
operations to improve 
reporting systems, including 
Medicare, Medicaid and 
health insurance reporting 
mechanisms.  
Departmental Define those 
responsible for access 
Identify those involved 
in prescribing systems 
Assess incidences of 
polypharmacy and issues 
Provide training and 
systematic support for the 
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point protection. at each organizational 
tier.  
related to poor 
performance levels and 
continually increasing 
polypharmacy rates.  




Appendix D: Evaluation Plan 
 The evaluation plan was utilized to determine variations in outcomes through the 
process of implementing policies and practice guidelines. Following is the organizational 
rubric that could be used to relate the progress of the program over time.  













    
Adverse Events  
 
 





Appendix E: Potential Organizational Implementation Outcomes 
 EHR Access Points Prescribing Systems Levels of Polypharmacy Reporting Systems 
Organizational Alcohol and Drug Use 
Child and Adolescent 
Services 
Geriatric Psychiatry 
Women’s Mental Health 
Clinical Services  
 
Start with prescribing 
mechanisms for 
departments with direct 
involvement in geriatric 
care, including Alcohol 
and Drug Use, Depression 
and Anxiety Specialists, 
Geriatric Psychiatry, 
Women’s Mental Health, 
and Clinical Services 
departments. 
The narrative reflections of 
members of the 
multidisciplinary team and 
assessments of their 
charting system suggest that 
polypharmacy occurs in 
almost 25 percent of cases 
seen in the mental health 
facility. Adverse events 
related to polypharmacy 
occur in only about 5 
percent of cases, but 
members of the team 
maintained that 
Only the billing 
department currently 
utilized technology-based 
reporting for their 
operations, based on the 
need for mechanized 
reporting systems for 





reduces the effectiveness of 
care.   
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Appendix F: Potential Departmental Implementation Outcomes 












and nurse practitioners all 
have prescribing 
responsibilities that can be 
impacted by the 
organizational change 
initiative. Nurses, 
psychologists and social 
workers may provide 
information within the 
EHR system that can 
impact decision-making 
regarding prescribing, 
including the presence of 
Higher overall rates of 
polypharmacy were noted in this 
population. About 30 percent of 
patients were noted as having 
multiple prescribers for the same 
medication. Nurses at in-take will 
be asked to interview patients 
regarding prescribed drug use, 
medication management, OTC 
drug use, and recreational drug use 
at the time of in-take. Nurses and 
nurse practitioners will be 
responsible for identifying or 
noting any prescription 
After implementation, the 
Geriatric Psychology 
department will relate 
concerns about the 
reporting mechanisms and 
other issues that might 
arise, e.g. the need for a 
shift in approaches to 
training or maintaining a 
skilled population of 
professionals in the rural 





prescriptions from other 
practitioners, the 
identification of OTC 
drug use, or the presence 
of comorbid substance use 
disorders. 
 
discrepancies or significant 
potential interactions, though it 
may be difficult to follow through 
with this kind of approach without 
the use of technology and without 
specific accurate information 
about existing prescriptions, 
medication management strategies, 
and communications between 





Appendix G: Evaluation Plan Results 
The evaluation plan was utilized to determine variations in the outcomes through sharing 
with others in the field the policies and practice guidelines from Appendices A-B. This 
information is provided in narrative form with some quotes from multidisciplinary team 
members to support specific assertions.  
 Planning Strategic 
Implementation 









went very well and 








creating a clear 
view of the 
implementation 
process that would 
be applied. (“The 




resulted in a 
comparison of old 
and new approaches 




(“Many of us didn’t 
realize how little we 
communicated until 







team approach, as 
noted through 





All members of the 
multidisciplinary 
team were on board 
The needed changes 
in policy were 
clearly aligned with 







views of the 
problem.  
 







utilized as a part of 
the directive for 
strategic change.  








could be compared 
to past rates to 
determine areas of 
continued 
improvement.  
Adverse Events The planning 
process reflected 
the fact that 
adverse events 
were not always 
identified as 







would include an 
evaluation of past 
events as a part of 
the strategic process 
in departments 
where the strategy 




team also identified 
discrepancies in 
views of adverse 
events.  
The attainment of 
zero adverse events 
was the goal to be 




outlined in the 
methods for 
implementation 
and evaluation.  
 
 
